These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38247224)

  • 1. Myocardial sodium-glucose cotransporter 2 expression and cardiac remodelling in patients with severe aortic stenosis: The BIO-AS study.
    Scisciola L; Paolisso P; Belmonte M; Gallinoro E; Delrue L; Taktaz F; Fontanella RA; Degrieck I; Pesapane A; Casselman F; Puocci A; Franzese M; Van Praet F; Torella M; Marfella R; De Feo M; Bartunek J; Paolisso G; Barbato E; Barbieri M; Vanderheyden M
    Eur J Heart Fail; 2024 Feb; 26(2):471-482. PubMed ID: 38247224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aortic valve area, stroke volume, left ventricular hypertrophy, remodeling, and fibrosis in aortic stenosis assessed by cardiac magnetic resonance imaging: comparison between high and low gradient and normal and low flow aortic stenosis.
    Barone-Rochette G; Piérard S; Seldrum S; de Meester de Ravenstein C; Melchior J; Maes F; Pouleur AC; Vancraeynest D; Pasquet A; Vanoverschelde JL; Gerber BL
    Circ Cardiovasc Imaging; 2013 Nov; 6(6):1009-17. PubMed ID: 24100045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of Patients with Low-Flow/Low-Gradient Severe Aortic Stenosis Who Underwent Aortic Valve Replacement.
    Fan XL; Zhang J; Wang C; Chong H; Zhang G; Xue Q; Tang Y; Han L
    Heart Surg Forum; 2017 Jul; 20(4):E124-E128. PubMed ID: 28846524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating collagen metabolites, myocardial fibrosis and heart failure in aortic valve stenosis.
    Kupari M; Laine M; Turto H; Lommi J; Werkkala K
    J Heart Valve Dis; 2013 Mar; 22(2):166-76. PubMed ID: 23798204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of left ventricular myocardial sodium-glucose cotransporter 1 expression in patients with end-stage heart failure.
    Sayour AA; Oláh A; Ruppert M; Barta BA; Horváth EM; Benke K; Pólos M; Hartyánszky I; Merkely B; Radovits T
    Cardiovasc Diabetol; 2020 Sep; 19(1):159. PubMed ID: 32998746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left ventricular mechanical dispersion in flow-gradient patterns of severe aortic stenosis with narrow QRS complex.
    Lavall D; Kuprat LK; Kandels J; Stöbe S; Hagendorff A; Laufs U
    Int J Cardiovasc Imaging; 2020 Apr; 36(4):605-614. PubMed ID: 31933102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow-gradient patterns in severe aortic stenosis with preserved ejection fraction: clinical characteristics and predictors of survival.
    Eleid MF; Sorajja P; Michelena HI; Malouf JF; Scott CG; Pellikka PA
    Circulation; 2013 Oct; 128(16):1781-9. PubMed ID: 24048203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of SGLT2 inhibition in human kidney proximal tubular cells--renoprotection in diabetic nephropathy?
    Panchapakesan U; Pegg K; Gross S; Komala MG; Mudaliar H; Forbes J; Pollock C; Mather A
    PLoS One; 2013; 8(2):e54442. PubMed ID: 23390498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum dihydrotestosterone levels are associated with adverse myocardial remodeling in patients with severe aortic valve stenosis before and after aortic valve replacement.
    Schafstedde M; Nordmeyer J; Berger F; Knosalla C; Mertins P; Ziehm M; Kirchner ML; Regitz-Zagrosek V; Kuehne T; Kraus M; Nordmeyer S
    Am J Physiol Heart Circ Physiol; 2022 Nov; 323(5):H949-H957. PubMed ID: 36206048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in natural history of low- and high-gradient aortic stenosis from nonsevere to severe stage of the disease.
    Herrmann S; Fries B; Liu D; Hu K; Stoerk S; Voelker W; Ruppert C; Lorenz K; Ertl G; Weidemann F
    J Am Soc Echocardiogr; 2015 Nov; 28(11):1270-1282.e4. PubMed ID: 26321001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes concomitant to aortic stenosis is associated with increased expression of NF-κB and more pronounced valve calcification.
    Kopytek M; Mazur P; Ząbczyk M; Undas A; Natorska J
    Diabetologia; 2021 Nov; 64(11):2562-2574. PubMed ID: 34494136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac Reversibility and Survival After Transcatheter Aortic Valve Implantation in Patients With Low-Gradient Aortic Stenosis.
    Sato K; Seo Y; Ishizu T; Albakaa NK; Izumo M; Okada A; Izumi C; Inami S; Takeda Y; Onishi T; Izumi Y; Kumagai A; Fukuda T; Takahashi N; Kitai T; Iwano H; Sugawara S; Akasaka K; Harada K; Masaoka Y; Kusunose K; Tanabe K; Sakamoto T; Takamura T; Ieda M
    J Am Heart Assoc; 2023 Aug; 12(16):e029717. PubMed ID: 37581389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Causes and consequences of cardiac fibrosis in patients referred for surgical aortic valve replacement.
    Galat A; Guellich A; Bodez D; Lipskaia L; Moutereau S; Bergoend E; Hüe S; Ternacle J; Mohty D; Monin JL; Derumeaux G; Radu C; Damy T
    ESC Heart Fail; 2019 Aug; 6(4):649-657. PubMed ID: 31115164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcome in asymptomatic severe aortic stenosis: insights from the new proposed aortic stenosis grading classification.
    Lancellotti P; Magne J; Donal E; Davin L; O'Connor K; Rosca M; Szymanski C; Cosyns B; Piérard LA
    J Am Coll Cardiol; 2012 Jan; 59(3):235-43. PubMed ID: 22240128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimensionless Index in Patients With Low-Gradient Severe Aortic Stenosis and Preserved Ejection Fraction.
    Altes A; Thellier N; Rusinaru D; Marsou W; Bohbot Y; Chadha G; Leman B; Paquet P; Ennezat PV; Tribouilloy C; Maréchaux S
    Circ Cardiovasc Imaging; 2020 Oct; 13(10):e010925. PubMed ID: 33076698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of surgical aortic valve replacement on global and regional longitudinal strain across four flow gradient patterns of severe aortic stenosis.
    Grund FF; Myhr KA; Visby L; Hassager C; Mogelvang R
    Int J Cardiovasc Imaging; 2021 Jul; 37(7):2175-2187. PubMed ID: 33604765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapagliflozin: a sodium-glucose cotransporter 2 inhibitor, attenuates angiotensin II-induced cardiac fibrotic remodeling by regulating TGFβ1/Smad signaling.
    Zhang Y; Lin X; Chu Y; Chen X; Du H; Zhang H; Xu C; Xie H; Ruan Q; Lin J; Liu J; Zeng J; Ma K; Chai D
    Cardiovasc Diabetol; 2021 Jun; 20(1):121. PubMed ID: 34116674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of Mortality and Symptomatic Outcome of Patients With Low-Flow Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement.
    Mangner N; Stachel G; Woitek F; Haussig S; Schlotter F; Höllriegel R; Adam J; Lindner A; Mohr FW; Schuler G; Kiefer P; Leontyev S; Borger MA; Thiele H; Holzhey D; Linke A
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29654191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic proinflammatory-profibrotic response in aortic stenosis patients with diabetes and its relationship with myocardial remodeling and clinical outcome.
    Lee HJ; Park CS; Lee S; Park JB; Kim HK; Park SJ; Kim YJ; Lee SP
    Cardiovasc Diabetol; 2023 Feb; 22(1):30. PubMed ID: 36765354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transvalvular Flow, Sex, and Survival After Valve Replacement Surgery in Patients With Severe Aortic Stenosis.
    Guzzetti E; Poulin A; Annabi MS; Zhang B; Kalavrouziotis D; Couture C; Dagenais F; Pibarot P; Clavel MA
    J Am Coll Cardiol; 2020 Apr; 75(16):1897-1909. PubMed ID: 32327100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.